Literature DB >> 172575

Determination of B protein of low density lipoprotein directly in plasma.

A Sniderman, B Teng, M Jerry.   

Abstract

Quantitation of the apoprotein constituents of lipoproteins has extended our knowledge of plasma lipid transport. Previously, B protein content of low density lipoprotein could be measured by radial immunodiffusion only after ultracentrifugation. However, if performed in 1.5% agarose gel with standards and measured at 18 hr rather than at equilibrium, low density lipoprotein B protein can be measured directly in plasma, eliminating the need to separate very low density lipoprotein.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 172575

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  13 in total

1.  Low density lipoprotein. A metabolic pathway for return of cholesterol to the splanchnic bed.

Authors:  A Sniderman; D Thomas; D Marpole; B Teng
Journal:  J Clin Invest       Date:  1978-04       Impact factor: 14.808

2.  Impaired response of fibroblasts from patients with hyperapobetalipoproteinemia to acylation-stimulating protein.

Authors:  K M Cianflone; M H Maslowska; A D Sniderman
Journal:  J Clin Invest       Date:  1990-03       Impact factor: 14.808

3.  Metabolic basis of hyperapobetalipoproteinemia. Turnover of apolipoprotein B in low density lipoprotein and its precursors and subfractions compared with normal and familial hypercholesterolemia.

Authors:  B Teng; A D Sniderman; A K Soutar; G R Thompson
Journal:  J Clin Invest       Date:  1986-03       Impact factor: 14.808

Review 4.  Apoproteins: determinants of lipoprotein metabolism and indices of coronary risk.

Authors:  G Thompson
Journal:  Br Heart J       Date:  1984-06

5.  Apolipoprotein B amino acid 3611 substitution from arginine to glutamine creates the Ag (h/i) epitope: the polymorphism is not associated with differences in serum cholesterol and apolipoprotein B levels.

Authors:  C F Xu; N Nanjee; M J Tikkanen; J K Huttunen; P Pietinen; R Bütler; F Angelico; M Del Ben; B Mazzarella; R Antonio
Journal:  Hum Genet       Date:  1989-07       Impact factor: 4.132

6.  Composition and distribution of low density lipoprotein fractions in hyperapobetalipoproteinemia, normolipidemia, and familial hypercholesterolemia.

Authors:  B Teng; G R Thompson; A D Sniderman; T M Forte; R M Krauss; P O Kwiterovich
Journal:  Proc Natl Acad Sci U S A       Date:  1983-11       Impact factor: 11.205

7.  Cholesterol-lowering effect of mevinolin, an inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme a reductase, in healthy volunteers.

Authors:  J A Tobert; G D Bell; J Birtwell; I James; W R Kukovetz; J S Pryor; A Buntinx; I B Holmes; Y S Chao; J A Bolognese
Journal:  J Clin Invest       Date:  1982-04       Impact factor: 14.808

8.  Association of coronary atherosclerosis with hyperapobetalipoproteinemia [increased protein but normal cholesterol levels in human plasma low density (beta) lipoproteins].

Authors:  A Sniderman; S Shapiro; D Marpole; B Skinner; B Teng; P O Kwiterovich
Journal:  Proc Natl Acad Sci U S A       Date:  1980-01       Impact factor: 11.205

9.  Obesity and cardiovascular disease risk factors in black and white girls: the NHLBI Growth and Health Study.

Authors: 
Journal:  Am J Public Health       Date:  1992-12       Impact factor: 9.308

10.  Selective removal of apolipoprotein B-containing serum lipoproteins from blood plasma.

Authors:  W Stoffel; T Demant
Journal:  Proc Natl Acad Sci U S A       Date:  1981-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.